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ABSTRACT
Motif overrepresentation analysis of proximal
promoters is a common approach to characterize
the regulatory properties of co-expressed sets of
genes. Here we show that these approaches
perform well on mammalian CpG-depleted promoter
sets that regulate expression in terminally dif-
ferentiated tissues such as liver and heart. In
contrast, CpG-rich promoters show very little over-
representation signal, even when associated with
genes that display highly constrained spatio-
temporal expression. For instance, while ~50% of
heart specific genes possess CpG-rich promoters
we find that the frequently observed enrichment of
MEF2-binding sites upstream of heart-specific
genes is solely due to contributions from CpG-
depleted promoters. Similar results are obtained
for all sets of tissue-specific genes indicating that
CpG-rich and CpG-depleted promoters differ funda-
mentally in their distribution of regulatory inputs
around the transcription start site. In order not to
dilute the respective transcription factor binding
signals, the two promoter types should thus be
treated as separate sets in any motif overrepre-
sentation analysis.
INTRODUCTION
How cells establish and maintain their transcriptome
remains one of the fundamental questions in cell biology.
Transcription factors together with DNA-methylation,
histone modiﬁcations and micro RNAs are the key
components of the regulatory repertoire of the cell.
Detection of transcription factor (TF)-binding site
motifs common to a set of co-expressed genes is a
central component of the in silico characterization of
transcriptional regulation and transcriptional regulatory
networks. In the absence of comprehensive genome-wide
experimental TF-binding data, the standard bioinfor-
matics procedure starts with the extraction of putative
promoter sequences for the co-expressed genes. The
sequences are sometimes further reﬁned by phylogenetic
footprinting (1,2). Subsequently, algorithms are applied
that either try to ﬁnd new DNA sequence motifs
overrepresented in the promoters (3,4), or that search
the sequence space for occurrences of known TF-binding
motifs (5). The latter approach relies on databases like
JASPAR (6) and Transfac (7) to provide motif
descriptions for the TFs involved in the regulation of the
genes of interest. With the ever growing number of
characterized binding motifs such approaches are
becoming increasingly popular. For a number of
applications, overrepresentation calculations based on
the annotation of discrete-binding sites (1) are being com-
plemented with aﬃnity based approaches, which avoid the
artiﬁcial separation between binding sites and non-binding
sites in the prediction of TF target promoters but instead
assign continuous binding probabilities to all sites in the
sequence based on thermodynamic considerations (2,8,9).
Such aﬃnity based methods were shown to emulate
the in vivo TF-binding behavior more quantitatively than
hit-based approaches (10,11). When applied to sets of
tissue-speciﬁc genes overrepresentation analyses and
aﬃnity based approaches were able to identifying key
regulators for a limited number of gene sets derived
from e.g. muscle and liver while they largely fail to
produce meaningful results for many other tissues such
as lung and brain.
To understand the source of the underlying diﬃculties
for enrichment testing more deeply, we need to look at
what is known about promoters and their binding site
content. The classical textbook depiction of a eukaryotic
proximal promoter shows the core promoter ﬂanked by
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polymerase II core promoter thereby typically includes
several sequence elements such as an initiator signal
coinciding with the transcription start site (TSS), a
TATA box and two or three other motifs such as a
CAAT or GC-box [for a review of these elements, see
e.g. (12,13)]. Alternatively, the whole promoter can
either be partially or completely overlapped by a CpG
island. In line with this model, Saxonov (14) made the
striking observation that the CpG content of vertebrate
promoters shows a distinct bimodal distribution. Using
the central dip in this distribution as demarcation line
about half of the promoters can be classiﬁed as having
high CpG content (HCPs) while the others are considered
to have low CpG content (LCPs).
Many pioneering vertebrate enrichment analyses used
promoters of genes expressed at a high level in a termi-
nally diﬀerentiated tissue. Those promoters were typically
of the LCP class and had a landmark TATA box about
30-bp upstream of TSSs (15). On the other hand,
ubiquitouslyexpressed(‘housekeeping’)genesanddevelop-
mental regulators, typically lack a TATA box but overlap
with a CpG island thus falling in the HCP class. This
broad dichotomy is statistically very convincing, but by
no means perfect. More recent genome-wide studies
revealed that a TATA box is present in only a minority
of tissue-speciﬁc promoters (16,17) and together with
other elements can occur also in CpG-rich promoters
(18). In accordance with this, many tissue-speciﬁc genes
from brain (19) and testis (20) do not have TATA-box
containing promoters characteristic of genes expressed
speciﬁcally in liver or muscle.
In this article we show that, while most sets of tissue-
speciﬁc genes contain a considerable percentage of CpG-
rich promoters, the observable tissue-speciﬁc motif
overrepresentation information within proximal pro-
moters is coming almost exclusively from CpG-depleted
promoters. In contrast, CpG-rich promoters turn out to
be of little or no utility for this type of analysis, even when
the genes driven by them have clear tissue preference. We
show that an a priori separation of the two promoter
classes (LCP and HCP) gives a stronger, more robust,
and spatially constrained binding aﬃnity signal in the
CpG-depleted promoters, and therefore recommend this
as a general approach for the analysis of motif enrichment
in co-regulated gene sets.
MATERIALS AND METHODS
Expression data and tissue-specificity
The expression of a given gene in one of the 15 mouse
tissues (Figure 1) is determined by analyzing correspond-
ing EST clusters from the GeneNest database (21), which
includes the annotation of the originating tissue for each
EST. To detect EST clusters whose distribution of ESTs
derived from various tissues diﬀer signiﬁcantly from the
expected distribution we applied a  
2-test. All clusters
with a P-value <10
 3 were subjected to a binomial test
such that we obtain a P-value describing the likelihood of
observing a given number of ESTs from a given tissue in
an EST cluster of given size. These EST cluster P-values
reﬂect the degree of over-expression of a given gene in a
given tissue and were successfully used previously to
predict tissue-speciﬁc expression of genes (9,21). Here we
use the P-values to rank all genes with respect to a given
tissue.
For the analysis of microarray data we refer to the GNF
data set from Su et al. (22). After taking the mean expres-
sion intensity across replicate microarrays we compute a
Z-score for each gene across all tissues. These Z-scores are
subsequently used to rank all genes for a given tissue.
Sequence data and promoter CpG content
All mouse promoter sequences as well as the annotation of
the corresponding TSSs for 28205 mouse genes are taken
from the Ensembl database version 46 (23). The nor-
malized CpG content of a given promoter measures the
ratio of observed over expected CpGs in the promoter and
is computed using the following equation:
Normalized CpG ¼
Observed CpGs
Observed Gs þ Cs ðÞ =2 ðÞ
2 1
where all Gs and Cs in the region ranging from  500 to
+500bp around the TSS are being considered. In general,
a normalized CpG content <1 indicates that the promoter
has less CpGs than expected based on its overall GC
content. Here, based on the bimodality of the normalized
CpG content in vertebrates, promoters with normalized
CpG content <0.5 are classiﬁed as CpG-depleted (LCP)
while promoters with CpG 0.5 are considered CpG-
rich (HCP). To avoid a strong inﬂuence of only predicted
Ensembl genes with potentially random promoter com-
position we restrict the enrichment analysis to those 18
938 mouse genes for which unigene EST clusters have
been identiﬁed.
Affinity predictions and hit based-binding site annotation
We rely on the collection of 588 vertebrate position
frequency matrices (PFM) provided by JASPAR (6) and
the Transfac database version 11.1 (7) to describe the
binding motif of a given TF. PFMs report the frequency
with which a certain base occurs at a given position in
alignments of known binding sites of a given TF. To
predict the binding strength of a given TF to a promoter
sequences we utilize the TRAP method (11). In contrast to
motif matching algorithms which make a binary distinc-
tion between binding sites and non-binding sites, TRAP
avoids this artiﬁcial separation by instead computing the
occupancy of a TF to each site in the sequence using
equation:
pi ¼
R0eEi   ðÞ
1 þ R0eEi   ðÞ 2
where DEi( ) is the energy diﬀerence or mismatch
energy—scaled by the parameter  —between the binding
energy of the factor to site i and the lowest binding energy
possible with the factor bound to its consensus site. The
second matrix dependent parameter R0 sets the binding
energy of the factor to the consensus site as well as the
6306 Nucleic Acids Research, 2009, Vol. 37,No. 19TF concentration. The nucleotide dependent mismatch
energies for each site in the promoter sequence are
computed as follows:
Ei   ðÞ ¼  
1
 
X
 ¼A,C,G,T
ln
 i,max
 i, 
  
3
where vi,max is the frequency of the consensus base at
position i in the PFM and vi,  is the frequency of the
observed base at position i in the matrix. Eventually,
TRAP obtains the expected number hNi of TFs bound
to the sequence window by summing over the individual
probabilities from all sites in the window with length L:
N hi ¼
X L
i¼0
pi: 4
Importantly, aside from avoiding an artiﬁcial discreti-
zation between bound and unbound states hNi also
allows for a more natural ranking of target promoter
sequences with respect to a given TF then do discrete hit
counts. As input TRAP requires for each TF a PFM
suitable for computing the mismatch energies DE,a
DNA sequence of interest and the setting of the two
parameters   and R0. As was derived previously,   is set
to a value of 0.7 for all matrices and R0 is derived for each
matrix individually using the formula:
R0 ¼ exp 0:6   W   6:0 ðÞ 5
where W is the number of informative positions in the TF
matrix, which are deﬁned as every column in the PFM
with information content exceeding 0.1 bits. The informa-
tion content of position i in the matrix is computed as the
Kullback–Leibler entropy given by:
Ii ¼ 2 þ
X
 ¼A,C,G,T
 i,  log2  i,  6
where  i,  is the frequency of base a at position i.
Matrix positions which fall below the entropy cutoﬀ do
not contribute to the mismatch energy in equation
[Equation (3)].
Discrete binding sites for a given TF are being
annotated using a standard approach of shifting a
position speciﬁc score matrix derived from the PFMs
over a promoter sequence. Sites exceeding a score thresh-
old that balances the expected number of false positive
hits with the expected number of false negatives are
annotated (24).
Enrichment testing using PASTAA and Z-scores
For the enrichment analysis based on continuous
TF-binding aﬃnities returned by TRAP we utilize the
recently published PASTAA method (9). PASTAA starts
by ranking all mouse genes promoters according to their
predicted aﬃnity for a given TF. At the same time the
genes are also ranked according to their association with
a given tissue measured by the EST enrichment P-values.
After applying a cutoﬀ to the ranked aﬃnity and tissue
lists a hypergeometric test is used to determine the
signiﬁcance of the overlap between the top target genes
of the TF and the top ranking genes of the tissue.
Cutoﬀs on the two lists are thereby chosen iteratively in
such a way that the obtained hypergeometric P-values are
minimized (see Supplementary Figure S1 for details). The
negative logarithms of these optimal P-values are
subsequently used as aﬃnity enrichment scores.
To test for an enrichment of discrete TF-binding sites
obtained from the balanced cutoﬀ method (24) within
promoters of tissue-speciﬁc genes we utilize a test statistic
published previously by Sui et al. (1). Hereby, for each
factor and tissue the following Z-score is computed:
Z ¼
x    
 
7
where x is the number of binding sites residing in the
promoters of the genes assigned to a given tissue, m is
the average number of binding sites residing in the
promoters of the background set (here all genes not
assigned to the tissue) and s is the variance of the
number annotated hits over all promoters in the back-
ground set. For a given tissue the ﬁve PFMs with largest
Z-score are reported.
Shifting window approach to detect promoter regions
with highest TF-binding affinity
For a given TF to assess a preference in the location of
maximal aﬃnity with respect to the TSS we shift 200-bp
windows inconsecutive stepsof 100bpacross thepromoter
regions ranging from  1-kb upstream to +1-kb down-
stream of the TSSs. For each window start position we
compute the binding aﬃnity for the TF to the 200-bp
sequence in the window. To detect a preference in the
binding location among promoters of tissue-speciﬁc
genes we retain for each gene the location of the window
with highest aﬃnity (Supplementary Figure S2).
Subsequently we rank these windows based on their
aﬃnity and report the location of the top 50 windows
among the 500 genes assigned to a given tissue.
Similarly, to ﬁnd the location of strongest TF-binding
aﬃnity enrichment among tissue-speciﬁc genes we shift
200-bp windows across the promoters of all 18938
genes. PASTAA is then applied to evaluate the signiﬁ-
cance of the overlap between 500 tissue-speciﬁc genes
and the target genes predicted based on the aﬃnities
from the 200-bp windows starting at a given position.
Matching LCP and HCP genes
In order to avoid a systematic bias in the enrichment
analysis towards genes with CpG-depleted promoters,
which on average tend to have more signiﬁcant tissue
enrichment, we ﬁrst select for each tissue the set of 500
CpG-rich genes with highest speciﬁcity for the tissue. We
then construct a set of 500 genes with CpG-depleted
promoters by selecting for each gene in the HCP set the
LCP gene with the most closely matching but not more
signiﬁcant tissue P-value (Supplementary Figure S3). The
PASTAA enrichment analysis is then performed on both
the HCP and matched LCP set separately with back-
ground sets consisting of all the other HCP genes
Nucleic Acids Research, 2009,Vol.37, No. 19 6307(10996) or LCP genes ( 6942) with less signiﬁcant tissue
enrichment, respectively. It has to be noted that the above
procedure of constraining the LCP gene sets causes a con-
siderable reduction in observed enrichment scores when
compared to LCP sets constructed by simply taking the
500 most speciﬁc LCP genes for each tissue. Alternatively,
we therefore also performed enrichment testing on either
the top 500 genes for each tissue irrespective of CpG
content or the 500 most tissue-speciﬁc LCP genes. In the
former case, all other mouse genes (18438) are used as
background set, in the latter case all other 6942 LCP
genes.
Lastly, tissue gene sets may also be deﬁned using a
cutoﬀ on the tissue speciﬁcity P-values or Z-scores. This
procedure oﬀers the advantage that tissue sets do not
contain genes with limited or no real speciﬁcity for the
respective tissue. Enrichment scores can thus be expected
to be overall stronger. On the other hand, this procedure
results in LCP and HCP sets of sometimes very diﬀerent
size thereby making the subsequently obtained TF enrich-
ment scores less well comparable. To ensure that the inclu-
sion of less tissue speciﬁc genes into the gene sets does not
result in enrichment artifacts we performed enrichment
testing also on tissue speciﬁc LCP and HCP gene sets
deﬁned by a cutoﬀ of 10
 3 on the EST P-values. Results
of this analysis closely resemble those obtained from the
tissue gene sets of static size 500 and are shown in the
Supplementary Data.
An overview of the diﬀerent ways to deﬁne tissue sets
and the corresponding enrichment analyses is shown in
Supplementary Figure S4.
RESULTS
Typical sets of tissue-specific genes contain a considerable
fraction of genes with CpG-rich promoters
The construction of a set of co-expressed genes with
tissue-speciﬁc expression pattern is a prerequisite for any
motif overrepresentation analysis aimed at ﬁnding TFs
involved in the regulation of the genes. It has become
textbook knowledge that promoters of tissue-speciﬁc
genes tend to be CpG-depleted while housekeeping genes
with broad expression patterns have CpG-rich promoters
(25). However, when background gene sets are not chosen
carefully and controlled for GC content, TFs with
GC-rich binding motifs such as SP1 (consensus sequence
GGGGCGGGGT) tend to be found as the most
overrepresented TF-binding motifs (9) indicating a consid-
erable contributions from genes with CpG-rich promoters
to sets of tissue-speciﬁc genes. We therefore ﬁrst analyze to
what extent the assumption of tissue-speciﬁc genes having
only CpG-depleted promoters holds true for comprehen-
sive sets of tissue-speciﬁc genes derived from either EST
or microarray data. Such gene sets, often containing
hundreds of genes, are frequently used in overrepre-
sentation analysis aimed at identifying common regulating
TFs (26–31).
To this end we compute for each promoter the CpG
content given by the ratio between the numbers of
observed versus expected CpG dinucleotides around the
TSS (see ‘Materials and Methods’ section). In mouse, the
resulting bimodal CpG distribution across all promoters
dips at roughly 0.5 (see black line in Figure 1a). We thus
set the border for separating LCP versus HCP to this
value resulting in about 46% of all Ensembl mouse
promoters falling into the HCP category.
For tissue-speciﬁc genes we ﬁnd that the percentage of
LCP and HCP promoters depends strongly on the tissue
under consideration (Figure 1b). While promoters of liver-
speciﬁc genes are strongly CpG-depleted, 70–80% of
promoters from genes expressed speciﬁcally in brain are
CpG-rich. Results are hereby comparable between tissue
gene sets derived from microarray (22) and EST data (21).
As expected, over all tissues there is a clear trend for the
most tissue-speciﬁc genes to fall into the class of CpG-
depleted promoters. However, with the exception of
liver, even when restricting the analysis to only the 50
most speciﬁc genes in each tissue a considerable pro-
portion of promoters are CpG-rich. As exempliﬁed for
diﬀerently sized sets of heart-speciﬁc genes (Figure 1a),
larger gene sets even tend to contain an excess of CpG-
rich promoters compared to what is expected based on the
CpG distribution across all 28205 Ensembl mouse
promoters (Figure 1b and c). We conclude that gene sets
derived based on tissue-speciﬁcity typically contain a
mixture of genes belonging to the LCP and HCP
categories and are by no means only composed of genes
with CpG-depleted promoters.
General TFs associate with both, HCP and LCP genes,
across all tissues
Having established that most tissue-speciﬁc gene sets
contain a considerable percentage of genes with CpG-
rich promoters, we next investigate whether binding
signals for general TFs show a tendency to occur in
CpG-rich or CpG-depleted promoters and whether such
a preference is tissue-speciﬁc. To this end, we compute
binding aﬃnities for 200-bp sequence windows that are
shifted in steps of 100bp along all promoters. In order
to assess a possible preference of a factor for high or
low CpG promoters we split the tissue gene sets into
two groups. The ﬁrst group contains for each tissue the
500 most speciﬁcally expressed HCP genes. The second
group contains the 500 LCP genes whose expression
P-values match most closely those of the genes put into
the HCP group but with the restriction of being less tissue-
speciﬁc than the corresponding HCP gene (Supplementary
Figure S3). Subsequently, we report for each factor the
locations of windows with highest aﬃnity in each gene
set (see ‘Materials and Methods’ section and Figure S2).
As shown in Supplementary Figures S5 and S6, we ﬁnd a
weak trend for the general TFs and core promoter motifs
to occur preferentially in CpG-rich promoters. The
exceptions are YY1, a general TF implicated in pinpoint-
ing the transcription start position, whose high aﬃnity
sites are found exclusively within 100-bp downstream of
CpG-rich promoters, and the TATA box motif which
occurs more frequently upstream of CpG-depleted rather
than CpG-rich promoters. As might be expected, when
performing enrichment testing (see ‘Materials and
6308 Nucleic Acids Research, 2009, Vol. 37,No. 19Methods’ section) we ﬁnd none of these general motifs to
be strongly overrepresented in any of the tissue-speciﬁc
gene sets (see Supplementary Figure S8 for results from
the CAAT box).
Location of sites with maximal affinity for HNF1 and
MEF2 demonstrates strong difference in regulatory
input to CpG-rich and CpG-depleted promoters
We now turn to TFs with tissue-speciﬁc activity and ask
whether high aﬃnity regions for such factors occur
preferentially in the CpG-rich or CpG-depleted promoters
of genes with tissue-speciﬁc expression. Two of the best
described associations between sets of tissue-speciﬁc genes
and TFs are that of hepatocyte nuclear factor, HNF1,
with sets of liver speciﬁc genes, and that of the muscle
enhancer factor, MEF2, with sets of muscle and heart
speciﬁc genes (1,9,28,30,32). We therefore chose these
two tissues and factors as a detailed test case before
investigating the situation for a wider range of tissues
and TFs. To identify regions of high aﬃnity for HNF1
and MEF2 we again report the location of sequence
windows with highest aﬃnity with respect to the TSSs
(see ‘Materials and Methods’ section).
As shown in Figure 2a and b, high aﬃnity windows of
HNF1 and MEF2 accumulate in proximal promoters of
the 500 most liver and heart speciﬁc genes, between 0 and
200bp upstream of the corresponding TSSs. Evaluating
separately the set of 500 most tissue-speciﬁc HCP genes
and the set of 500 LCP genes whose expression P-values
match most closely those of the genes in the HCP group
(Figure S3) reveals that high aﬃnity windows accumulate
only near the TSS of CpG-depleted promoters (Figure 2a
and b) while the strongest aﬃnities observed in HCP genes
are scattered randomly across the promoters (for the
situation across the other tissues see Supplementary
Figure S7).
Figure 1. (a) Bimodal CpG distribution across the promoters of the 50, 200 or 500 most heart-speciﬁc genes. The fraction of HCPs in the 200 and
500 gene sets is larger than expected based on the CpG content across all mouse promoters (the black line indicates the expected CpG distribution
for random gene sets of size 500). (b) and (c) show the contribution of HCP genes to other tissue sets of indicated size based on EST or microarray
data, respectively. The contribution of HCP promoters usually increases with gene set size and is >20% even for most sets of size 50. Sets with more
than 200 genes often contain an excess of HCP genes compared to the fraction of 46% of HCPs across all Ensembl promoters (indicated by
horizontal lines).
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accumulation of high aﬃnity sites is restricted to only
the genes speciﬁcally expressed in the corresponding
tissue, we perform enrichment testing as described in
‘Materials and Methods’ section. As shown in Figure 2c
and d when analyzing the 500 most tissue-speciﬁc genes we
ﬁnd a clear peak in TF target gene enrichment only when
performing the analysis for the sequence windows directly
upstream of the TSS. The accumulation of high aﬃnity
sites for HNF1 and MEF2 near the TSS is thus restricted
to the promoters of genes from the corresponding tissues.
Performing the enrichment test separately on the 500
HCP and 500P-value matched LCP genes shows that
the observed associations between HNF1 and liver,
and MEF2 and heart, are almost exclusively due to the
contributions from CpG-depleted promoters. Similar
enrichment scores for HNF1 and MEF2 are obtained
also only for CpG-depleted promoters from kidney and
muscle, respectively, but not for promoters from other
tissues (see Supplementary Figure S8 for the target gene
enrichment in other tissues).
Enriched motifs reside in CpG-depleted promoters
across all tissue-specific gene sets
We extend the above analysis from liver and heart to all
15 tissues from Figure 1 and ﬁrst analyze where across
the tissue-speciﬁc promoters we ﬁnd the strongest enrich-
ment for high aﬃnity sites from any of the 588 vertebrate
TFs from Transfac (7) and JASPAR (6). Performing the
enrichment testing on the 500 most speciﬁc genes of each
tissue, irrespective of the CpG content of their promoters,
we ﬁnd a very strong peak in TF aﬃnity enrichment
within 200-bp upstream of the TSS across all tissues
except lung and breast (see Supplementary Figure S9a).
The TFs corresponding to these strongest enrichments
match well to the factors that have previously been
implied as potential regulators for these tissues [Table 1;
(33–40)]. Following the procedure of separating tissue-
speciﬁc genes into HCP and matched LCP groups, we
next assessed whether the observed enrichment stems
from high aﬃnity sites in CpG-rich or depleted promoters.
As shown in Figure 3a), when performing the enrichment
analysis on the HCP groups we ﬁnd no clear peak in
Figure 2. Enrichment of high aﬃnity sites for HNF1 and MEF2 near the TSS of liver- and muscle-speciﬁc genes with CpG-depleted promoters. (a)
and (b) Sequence windows with highest aﬃnity are preferentially located directly upstream of the TSS (red bars). This signal is due to sites in the
CpG-depleted promoters as no preferential binding pattern is observed when restricting the analysis to CpG-rich promoters (compare blue and
yellow bars for results from CpG-rich and CpG-depleted genes, respectively). (c) and (d) show the corresponding PASTAA enrichment scores (see
‘Materials and Methods’ section) for each sequence window as well as the separate sets of high and low CpG promoters.
6310 Nucleic Acids Research, 2009, Vol. 37,No. 19aﬃnity enrichment near the TSS for any of the tissues
except testis. Also, for most tissues the enrichment
analysis returns general binding motifs such as TATA
and CAAT as the most strongly associated motifs. In
contrast, very strong enrichment directly upstream of the
TSS is observed when performing the analysis for the
groups of 500P-value matched LCP genes (Figure 3b).
In fact, for most tissues a better enrichment is obtained
when performing the analysis on all CpG-depleted
promoters alone rather than on LCP and HCP genes
combined (Table 1 and Supplementary Figure S9b).
Together these ﬁndings indicate a lack of tissue-speciﬁc
binding signals in the proximal regions of HCP promoters
and a very strong accumulation of binding signals right
upstream of the TSS of LCP genes. An interesting excep-
tion is observed for the neuron-restrictive silencing factor,
NRSF, whose binding signals are enriched much more
strongly in brain speciﬁc genes of the HCP (enrichment
P-value 8.3 10
 7) rather than the LCP class (P-value
7.8 10
 2, Table 1).
TFs associate preferentially with CpG-depleted promoters
Having tested the enrichment across all tissues, we now
switch from the tissue-centric to a TF-centric view and
assess with which promoter class each of the 588 verte-
brate TF matrices associates preferentially. To this end,
we again perform enrichment testing on the 15 tissue sets,
Figure 3. TF-binding aﬃnity enrichment near the TSS of tissue-speciﬁc genes with either CpG-rich (a) or CpG-depleted promoters (b). The height of
each bar corresponds to the PASTAA enrichment score of the most signiﬁcant association that is found for the corresponding tissue. With the
exception of testis, no signiﬁcant enrichment signals are detected when analyzing the tissue sets containing the 500 most speciﬁc CpG-rich promoters.
In contrast, enrichment peaks strongly for tissue-speciﬁc sets of 500 P-value matched LCP genes when computing TF-binding aﬃnities for 200-bp
windows directly upstream of the TSSs.
Table 1. Top ranking matrices for 200bp proximal promoters from LCP, HCP and joint gene sets
ALL LCP HCP
Brain EGR_Q6 5.90 CHCH_01 11.32 NRSF_01 6.08
Eye GATA1_03 16.62 GATA1_03 16.93 LRF_Q2 8.44
Liver HNF1_01 30.81 HNF4_Q6_01 38.27 NFY_Q6_01 8.00
Kidney HNF1_01 30.27 HNF1_01 24.02 NFY_Q6_01 5.18
Intestine HNF4_Q6_01 17.02 HNF4_Q6_01 16.87 MTATA_B 6.56
Stomach TATA_01 11.17 LMO2COM_02 9.18 TATA_C 6.81
Pancreas TATA_01 9.71 PTF1BETA_Q6 9.18 PEA3_Q6 6.93
Muscle SRF_C 11.58 MEF2_Q6_01 10.74 SRF_C 6.26
Heart MEF2_Q6_01 15.42 MEF2_Q6_01 13.77 SRF_Q5_02 5.97
Leukocyte NFKAPPAB_01 9.99 ELF1_Q6 14.29 OCT1_B 5.13
Spleen ICSBP_Q6 16.02 ICSBP_Q6 18.65 STAT1_01 6.62
Thymus ETS_Q6 12.20 ETS_Q6 17.34 ZF5_01 4.73
Lung NGFIC_01 4.90 ZF5_01 7.55 CAAT_01 4.51
Breast PEBP_Q6 6.11 SMAD4_Q6 7.09 IK2_01 3.87
Testis CREBP1CJUN_01 11.26 CREBP1CJUN_01 24.12 VMYB_02 12.06
For each tissue the top associated matrix and the corresponding enrichment score from PASTAA is shown (see ‘Materials and Methods’ section)
depending on whether the analysis was performed on all 500 tissue-speciﬁc promoters indiscriminate of CpG content, on the 500 tissue-speciﬁc genes
with CpG-rich or on the 500 tissue-speciﬁc genes with CpG-depleted promoters. Matrices in bold correspond to well documented TF-tissue
associations and are preferentially discovered for sets of LCP genes.
Nucleic Acids Research, 2009,Vol.37, No. 19 6311this time reporting the promoter location of the most sig-
niﬁcant association and the average CpG content of its
assumed target genes for each of the 588 vertebrate
matrices. As shown in Figure 4, about one third of all
matrices show the strongest association with any one of
the 15 tissues within 200-bp upstream of the TSS. For the
vast majority of factors the average CpG content of the
target genes is thereby smaller than 0.5, again indicating
that high aﬃnity peaks reside preferentially within CpG-
depleted promoters. A similar picture is observed not
only for the sequence window at the TSS but across the
whole promoter region ranging from  3kb to +3kb.
This ﬁnding also strongly underlines a fundamental diﬀer-
ence in the regulatory mechanisms of CpG-rich and
CpG-depleted promoters of tissue-speciﬁc genes.
General implications for enrichment testing
Several approaches for detecting overrepresented motifs in
promoter sets utilize the annotation of discrete TF-
binding sites rather than continuous binding aﬃnities
(1,41). To evaluate for such methods the eﬀect of having
HCPs included in sets of tissue-speciﬁc promoters, we
assess the top regulators for the tissues liver, kidney,
muscle and eye, as suggested by a Z-score statistic
applied to discrete binding site predictions. A similar sta-
tistic was used previously to determine an enrichment of
discrete binding sites in sets of co-regulated genes (1,9). As
shown in Table 2 and in accordance with previous studies,
when analyzing the top 500 kidney- and liver-speciﬁc
genes the approach recovers HNF1 and HNF4 as the
top associated regulators. In contrast, for the 500 most
muscle- and eye-speciﬁc genes we ﬁnd GC-rich motifs
including SP1 and WT1 as top ranking. The situation
worsens when performing the enrichment analysis on the
500 most tissue-speciﬁc HCP genes with the background
gene set consisting of all other 10996 HCP genes. In this
case, GC-rich motifs are found as top ranking in all tissues
(indicating that the tissue-speciﬁc HCP genes possess
particularly CpG-rich promoters). In contrast, when
using the 500P-value matched LCP genes (together with
the remaining  6942 LCP genes as background) we ﬁnd
well characterized TF–tissue associations for all tissues
including MEF2 for muscle and cone rod speciﬁc TF
CRX for eye. At the same time, general TFs such as
SP1 are not found among the top ranking factors in
either tissue. This ﬁnding indicates that an incorporation
of CpG-rich promoters in sets of co-regulated genes
hampers not only aﬃnity-based enrichment testing
approaches but also methods based on discrete binding
site predictions.
DISCUSSION
Traditionally, vertebrate genes are being divided into two
distinct classes based on the CpG content of their
promoters. While tissue-speciﬁc genes tend to possess
CpG-depleted promoters, housekeeping genes (broadly
expressed) usually have CpG-rich promoters. However,
as shown here, this picture is less clear-cut than generally
assumed with many tissue-speciﬁc genes falling into the
Table 2. Top ranking matrices returned by a hit based z-score statistic
ALL HCP matched LCP
Kidney
HNF1_01 SP1_Q6 HNF4_01
HNF4_Q6_01 SP1_Q4_01 HNF4_Q6_01
HNF4_01 SP1_Q6_01 P53_01
HNF1_C ZF5_01 HNF1_01
SP1_Q4_01 GC_01 COUP_01
Liver
HNF4_Q6_01 SP1_Q4_01 HNF4_Q6_01
HNF4_01 SP1_Q6 HNF4_01
DR1_Q3 GC_01 HNF1_C
HNF4_01_B SP1_Q6_01 COUP_01
COUP_01 SP1_Q2_01 DR1_Q3
Muscle
GC_01 ZF5_01 MEF2_02
SP1_Q6 AP2_Q6_01 MEF2_03
SP1_Q4_01 SP1_Q6 SRF_Q5_02
ZF5_01 WT1_Q6 DR1_Q3
WT1_Q6 E2F_Q2 SRF_Q6
Eye
AP2_Q6_01 AP2_Q6_01 P53_01
WT1_Q6 WT1_Q6 MZF1_02
SP1_Q6 ZF5_01 PAX4_04
SP1_Q4_01 SP1_Q6 GATA1_03
SP1_Q2_01 SP1_Q4_01 CRX_Q4
Experimentally veriﬁed TF–tissue associations (indicated in bold) are
found in liver and kidney when analyzing the top 500 genes for each
tissue. While no veriﬁed associations are detected when performing the
analysis on only HCP genes (all discovered motifs are GC rich) veriﬁed
associations are found for all tissue sets when analyzing P-value
matched LCP genes.
Figure 4. TF targets have low average CpG content. Yellow and blue
bars indicate the number of matrices whose target genes have an
average CpG content  0.5 and <0.5, respectively. Red bars indicate
the overall propensity to ﬁnd the most signiﬁcant association between
matrices and any of the tissues at a particular window position. About
a third of all matrices show the strongest association with any of the
tissues when computing the binding aﬃnities for the window ranging
from  200 to 0bp upstream of the TSS, indicating a strong location
preference for the proximal promoter (see red bars). The target genes of
the vast majority of matrices thereby have an average CpG content
<0.5 (compare yellow and blue bars).
6312 Nucleic Acids Research, 2009, Vol. 37,No. 19HCP rather than the LCP class. We ﬁnd that the amount
of tissue-speciﬁc regulatory TF-binding signals around the
TSS is thereby vastly diﬀerent for LCP and HCP
promoters. Consequently, any promoter content analysis
assessing the overrepresentation of TF motifs should start
by separate the two promoter classes.
In accordance with this paradigm, for set of tissue-
speciﬁc genes with CpG-depleted promoters we ﬁnd
many well characterized TF-tissue associations such as
hepatocyte nuclear factor (HNF1) with liver, and
pancreas speciﬁc TF (PTF1) with pancreas. Successful
predictions thereby stem from cis-regulatory elements
located usually within only 200-bp upstream of the TSS.
Analyzing HCP promoters proved to be much less suc-
cessful. A notable exception is the association of neuron-
restrictive silencing factor, NRSF, with brain speciﬁc
genes of the HCP class. Interestingly, this association is
not detected in the corresponding LCP class and also
appears less signiﬁcant when combining CpG-rich and
CpG-depleted promoters indicating that NRSF acts
preferentially on the transcription of CpG-rich promoters.
In general, while the overall enrichment scores across all
HCP categories are weak, motifs overrepresentation
analysis of the HCP genes revealed an accumulation of
core promoter elements in tissue-speciﬁc genes with
CpG-rich promoters. For instance, within 200-bp
upstream of the TSS we found NFY as the most
enriched motif in liver and muscle, TATA in intestine
and stomach and the CAAT box in lung. While these
motifs represent the very opposite to tissue-speciﬁc
signals, they demonstrate a general enrichment of such
core promoter elements in CpG-rich promoters of tissue-
speciﬁc genes. This suggests that such promoters might
tend to be activated diﬀerently from CpG-rich promoters
of broadly expressed genes.
A plausible explanation for the weak enrichment scores
across HCP genes is that regulatory elements driving
expression in these contexts are more likely to be outside
of ‘conventional’ promoter regions, and a typical analysis
in which a ﬁxed sequence range around the TSS is
analyzed either misses them or drowns them in a too
large sequence space (42). An increasing amount of evi-
dence indicates that many genes have key regulatory
elements at large distances in both directions from the
core promoter (31,43)—too large, in fact, for any
approach that takes a ﬁxed amount of upstream and/or
downstream sequence to work. For these, the only hope
for ﬁnding regulatory elements might come in the form of
exhaustive genome-wide experimental TF-binding data
from ChIP-seq and related technologies combined with
e.g. chromatin capture assays (44).
Another problem with enrichment testing in proximal
promoters might be caused by the presence of multiple
alternative promoters as expression data often does not
reveal which of them is used in a given context (45).
Similarly, in a large subset of individual vertebrate core
promoters, typically those overlapping a CpG island, TSS
positions are not unique but rather broadly distributed
(17). Therefore, taking a ﬁxed amount of sequence
around any given TSS is likely to result in a functionally
heterogeneous set, on which the interpretation of TF
content and their position relative to TSS becomes ambig-
uous. However, since the typical CpG-rich promoters
have TSS positions spread over a span of only 50–
200bp, this imprecision cannot by itself account for the
lack of tissue-speciﬁc signals reported here. In the worst
case, it would result in a slightly weaker association due to
the ambiguous determination of TSS position, and not the
almost complete absence of it that is observed.
CpG islands are relatively easy to ﬁnd in genomes of
tetrapod vertebrates; in many ﬁsh genomes, however, they
are much smaller and more diﬃcult to detect, although the
main distinction between CpG-depleted promoters with
well deﬁned TSSs and CpG-rich promoters with ambigu-
ous start positions still holds (A.C. Previti and B.
Lenhard, unpublished data). Of invertebrates, Drosophila
species were shown to have multiple types of core pro-
moters (46) that are associated with diﬀerent responsive-
ness to long-range enhancers and diﬀerent level of
tissue-speciﬁcity (47). It remains to be seen if genome
compaction has led to more of the promoters having the
majority of their regulatory elements close to the TSS.
Other model invertebrates were also shown to have a
distinct subset of genes responsive to long range enhancers
(48). It is tempting to conclude that the distinction
between promoters responding to proximal and distal
signals could be found in most metazoan genomes.
The speciﬁc enrichment of regulatory sequence elements
in only CpG-depleted promoters points to the potential
involvement of alternative mechanisms in the regula-
tion of tissue-speciﬁc expression of HCP genes. These
mechanisms likely include DNA methylation and
distinct histone modiﬁcations. With the recent advent of
technologies such as ChIP-seq new large-scale data will
become available soon that will allow to associate
speciﬁc histone modiﬁcations with speciﬁc expression
patterns across a variety of diﬀerent tissues.
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